Results 211 to 220 of about 1,109,482 (395)

Ischemic colitis during interferon treatment for chronic hepatitis C

, 2004
Yoshitaka Fukushima, Hitoshi Funatomi, Yuuji Aoyagi, Takaya Satou, Katurou Tubo, Tatuo Ozawa   +5 more
openalex   +2 more sources

Chronic Hepatitis C

Seminars in Liver Disease, 2004
openaire   +4 more sources

Direct-acting antivirals for chronic hepatitis C.

Cochrane Database of Systematic Reviews, 2017
J. Jakobsen, E. Nielsen, J. Feinberg, K. Katakam, Kristina Fobian, G. Hauser, G. Poropat, S. Djurisic, K. Weiss, Milica Bjelakovic, G. Bjelakovic, S. Klingenberg, Jian Ping Liu, D. Nikolova, R. Koretz, C. Gluud   +15 more
semanticscholar   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Factors associated with cardiovascular events after simultaneous liver–kidney transplant from the US Multicenter Simultaneous Liver–Kidney Transplant Consortium

Hepatology Communications, EarlyView., 2022
Abstract Cardiovascular disease is a leading complication after both liver and kidney transplantation. Factors associated with and rates of cardiovascular events (CVEs) after simultaneous liver–kidney transplant (SLKT) are unknown. This was a retrospective cohort study of adult SLKT recipients between 2002 and 2017 at six centers in six United Network ...
Jennifer Jo, Gonzalo Crespo, Dyanna Gregory, Jasmine Sinha, Jiaheng Xie, Min Zhang, John Magee, Pranab Barman, Yuval A. Patel, Aaron Schluger, Kara Walters, Scott Biggins, Natalia Filipek, Giuseppe Cullaro, Randi Wong, Jennifer C. Lai, Gabriel J. Perreault, Elizabeth C. Verna, Pratima Sharma, Lisa B. VanWagner   +19 more
wiley   +1 more source

T1004 Over-Utilization of Hepatitis C Antibody Testing and Its Impact on the Quality of Care in Patients With Chronic Hepatitis C Virus Infection

, 2010
Fasiha Kanwal, Tuyen Hoang, Steven M. Asch, Jennifer R. Kramer, Angelique Zeringue, Hashem B. El‐Serag   +5 more
openalex   +1 more source

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C

Hepatology, 2005
M. Ziol, A. Handra‐Luca, A. Kettaneh, C. Christidis, F. Mal, F. Kazemi, V. de Lédinghen, P. Marcellin, D. Dhumeaux, J. Trinchet, M. Beaugrand   +10 more
semanticscholar   +1 more source

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta, Luigi Angelo Fiorito, Roberta Vescovo, Anna Virgilio, Giulia Amato, Giuseppe Cimino   +5 more
wiley   +1 more source

Noninvasive tests for nonalcoholic fatty liver disease in a multi‐ethnic population: The HELIUS study

Hepatology Communications, EarlyView., 2022
Abstract Nonalcoholic fatty liver disease (NAFLD) is increasing in prevalence and severity globally, prompting noninvasive testing, yet limited data exist on noninvasive liver tests (NITs) including transient elastography (TE) in ethnically diverse populations.
Anne‐Marieke van Dijk, Yasaman Vali, Anne Linde Mak, Henrike Galenkamp, Max Nieuwdorp, Bert‐Jan van den Born, Adriaan Georgius Holleboom   +6 more
wiley   +1 more source

FREQUENCY OF TYPE 2 DIABETES MELLITUS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION

Journal of University Medical & Dental College, 2015
: BACKGROUND: In developing countries, Diabetes Mellitus and Hepatitis C virus infection are major public health problems. A range of extra-hepatic manifestation such as artharlgia, thyroiditis and Type 2 Diabetes Mellitus are associated with Hepatitis C
Sumera Riaz, Muhammad Siddique Khan Qadri, Khurram Sohail et al.   +2 more
doaj